Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 31 (2) , 461-479
- https://doi.org/10.1016/s0889-8553(02)00013-4
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- p53 Gene Mutation and Protein Accumulation during Neoplastic Progression in Barrett's EsophagusLaboratory Investigation, 2001
- Allelic Loss Involving the Tumor Suppressor Genes APC and MCC and Expression of the APC Protein in the Development of Dysplasia and Carcinoma in Barrett EsophagusAmerican Journal of Clinical Pathology, 2000
- Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinomaHistopathology, 1999
- Characterization of cytochrome P450 expression in human oesophageal mucosaCarcinogenesis: Integrative Cancer Research, 1999
- Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomasMolecular Carcinogenesis, 1998
- ras mutation and expression of theras-regulated genes osteopontin and cathepsin L in human esophageal cancerInternational Journal of Cancer, 1997
- Cancer Cell CyclesScience, 1996
- Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variablesInternational Journal of Cancer, 1995
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990